2012 Q3 Form 10-Q Financial Statement

#000110465912075028 Filed on November 07, 2012

View on sec.gov

Income Statement

Concept 2012 Q3
Revenue $1.491M
YoY Change
Cost Of Revenue $1.020M
YoY Change
Gross Profit $870.0K
YoY Change
Gross Profit Margin 58.35%
Selling, General & Admin $1.420M
YoY Change
% of Gross Profit 163.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.420M
YoY Change
Operating Profit -$550.0K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$554.0K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$554.0K
YoY Change
Net Earnings / Revenue -37.16%
Basic Earnings Per Share
Diluted Earnings Per Share -$59.72K
COMMON SHARES
Basic Shares Outstanding 9.205M shares
Diluted Shares Outstanding 9.205M shares

Balance Sheet

Concept 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.00M
YoY Change
Cash & Equivalents $23.98M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $900.0K
Other Receivables $0.00
Total Short-Term Assets $24.90M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $190.5M
YoY Change
Other Assets $4.300M
YoY Change
Total Long-Term Assets $195.4M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $24.90M
Total Long-Term Assets $195.4M
Total Assets $220.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00
YoY Change
Accrued Expenses $800.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.600M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $48.80M
YoY Change
Other Long-Term Liabilities $2.100M
YoY Change
Total Long-Term Liabilities $50.90M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.600M
Total Long-Term Liabilities $50.90M
Total Liabilities $53.57M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.619M
YoY Change
Common Stock $169.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.7M
YoY Change
Total Liabilities & Shareholders Equity $220.3M
YoY Change

Cashflow Statement

Concept 2012 Q3
OPERATING ACTIVITIES
Net Income -$554.0K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.000M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$112.3M
YoY Change
Cash From Investing Activities -$112.2M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 47.80M
YoY Change
NET CHANGE
Cash From Operating Activities 1.000M
Cash From Investing Activities -112.2M
Cash From Financing Activities 47.80M
Net Change In Cash -63.40M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $1.000M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1090000 USD
CY2012Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1922000 USD
CY2012Q3 us-gaap Assets
Assets
220253000 USD
CY2012Q3 acre Escrow Liability
EscrowLiability
1922000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
53570000 USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
92000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
169210000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1240000 USD
CY2011Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3000 USD
CY2011Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1194000 USD
CY2011Q4 us-gaap Other Assets
OtherAssets
205000 USD
CY2011Q4 us-gaap Assets
Assets
7587000 USD
CY2011Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
827000 USD
CY2011Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
200000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
1150000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6600000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
166683000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
us-gaap Interest And Fee Income Loans And Leases Held In Portfolio
InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio
4397000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-163000 USD
CY2012Q3 us-gaap Interest And Fee Income Loans And Leases Held In Portfolio
InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio
1889000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1491000 USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1044000 USD
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
398000 USD
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3307000 USD
acre Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
23400000 USD
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000 shares
CY2012Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
625000 USD
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares
us-gaap Professional Fees
ProfessionalFees
706000 USD
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Professional Fees
ProfessionalFees
292000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
827000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
496000 USD
acre General And Administrative Expenses Reimbursed To Affiliate
GeneralAndAdministrativeExpensesReimbursedToAffiliate
951000 USD
CY2012Q3 acre General And Administrative Expenses Reimbursed To Affiliate
GeneralAndAdministrativeExpensesReimbursedToAffiliate
632000 USD
us-gaap Noninterest Expense
NoninterestExpense
3528000 USD
CY2012Q3 us-gaap Noninterest Expense
NoninterestExpense
2045000 USD
us-gaap Net Income Loss
NetIncomeLoss
-221000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-554000 USD
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
102000 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-572000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5606840 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9205480 shares
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
142450000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
202000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3350000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1561000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
469000 USD
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
171000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
202000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
868000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
514000 USD
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
1053000 USD
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-25000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
386000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
311000 USD
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
185555000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-185423000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
113067000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
64277000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2090000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
102000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5723000 USD
us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
6295000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
165850000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3016000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
207855000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
22743000 USD
us-gaap Interest Paid Net
InterestPaidNet
589000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
334000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
61648 shares
acre Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Remainder Of Fiscal Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestRemainderOfFiscalYear
12622 shares
acre Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearTwo
22342 shares
acre Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Three
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearThree
16258 shares
acre Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Four
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearFour
11254 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold" size="2">Concentration of Credit Risk</font></i></b></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation insured limit.</font></p></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold" size="2">Use of Estimates in the Preparation of Financial Statements</font></i></b></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of investments.</font></p></td></tr></table>
CY2011Q4 acre Commitments
Commitments
11000000 USD
CY2011Q4 acre Funded Commitments
FundedCommitments
5055000 USD
CY2011Q4 acre Unfunded Commitments
UnfundedCommitments
5945000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 item
CY2012Q2 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
47300000 USD
CY2012Q2 us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
6300000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
690000 shares
acre Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Issued And Outstanding Common Stock Eligible
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfIssuedAndOutstandingCommonStockEligible
0.075 pure
us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
185661000 USD
acre Mortgage Loans On Real Estate Receipt Of Orgination Fee
MortgageLoansOnRealEstateReceiptOfOrginationFee
2002000 USD
us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
1896000 USD
us-gaap Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
132000 USD
CY2011Q4 us-gaap Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
5055000 USD
CY2011Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
125000000 USD
CY2012Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
308675000 USD
CY2012Q3 us-gaap Line Of Credit
LineOfCredit
48790000 USD
CY2012Q3 acre Commitments
Commitments
218400000 USD
CY2012Q3 acre Funded Commitments
FundedCommitments
192480000 USD
CY2012Q3 acre Unfunded Commitments
UnfundedCommitments
25920000 USD
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7700000 shares
CY2012Q2 us-gaap Share Price
SharePrice
18.50
CY2012Q2 acre Gross Proceeds From Issuance Of Shares In Initial Public Offering
GrossProceedsFromIssuanceOfSharesInInitialPublicOffering
142500000 USD
CY2012Q2 acre Adjustments To Additional Paid In Capital Stock Issued Underwriting Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedUnderwritingCosts
-5300000 USD
CY2012Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3400000 USD
CY2012Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
139100000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
5514 shares
CY2012Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1284000 USD
acre Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Five
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearFive
4686 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
67162 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23983000 USD
CY2012Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
871000 USD
CY2012Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2416000 USD
CY2012Q3 us-gaap Other Assets
OtherAssets
522000 USD
CY2012Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
812000 USD
CY2012Q3 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
175000 USD
CY2012Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
31000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2619000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1005000 USD
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
acre Number Of Subsequent Taxable Years Subject To Disqualification
NumberOfSubsequentTaxableYearsSubjectToDisqualification
P4Y
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
123000 USD
CY2012Q3 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
190539000 USD
CY2012Q3 us-gaap Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
192480000 USD

Files In Submission

Name View Source Status
0001104659-12-075028-index-headers.html Edgar Link pending
0001104659-12-075028-index.html Edgar Link pending
0001104659-12-075028.txt Edgar Link pending
0001104659-12-075028-xbrl.zip Edgar Link pending
a12-20206_110q.htm Edgar Link pending
a12-20206_1ex10d1.htm Edgar Link pending
a12-20206_1ex31d1.htm Edgar Link pending
a12-20206_1ex31d2.htm Edgar Link pending
a12-20206_1ex32d1.htm Edgar Link pending
acre-20120930.xml Edgar Link completed
acre-20120930.xsd Edgar Link pending
acre-20120930_cal.xml Edgar Link unprocessable
acre-20120930_def.xml Edgar Link unprocessable
acre-20120930_lab.xml Edgar Link unprocessable
acre-20120930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending